COMP <GO>
JCI vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Johnson Controls International plc Ordinary Share (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: JCI 6
— TMO 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $149.03 (-5.84%) • MKT CAP: $95.87B
balance-sheet
4.13
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JCI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | JCI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.40% | 41.00% | -4.60 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 15.60% | 9.30% | +6.30 | JCI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.9x | 30.4x | -9.50 | JCI | /valuation <GO> |
| Free Cash Flow Yield | 2.81% | 2.40% | +0.41 | JCI | /fcf-yield <GO> |
| Operating Margin | 17.00% | 17.40% | -0.40 | TMO | /operating-margins <GO> |
| Net Profit Margin | 13.90% | 15.10% | -1.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 2.80% | 3.90% | -1.10 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 0.24% | +0.78 | JCI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.13 | 4.50 | -0.37 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 6.70% | +0.10 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 59.1 | -10.80 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 0.94 | +0.04 | JCI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.1x | 36.3x | -9.20 | JCI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.87B | $262.22B | -$166.35B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | JCI REV | TMO REV | JCI GROSS % | TMO GROSS % | JCI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.60B | $44.56B | 36.4% | 44.0% | $2.62B | $6.29B |
| FY 2024 | $22.95B | $42.88B | 35.2% | 44.0% | $876.8M | $7.27B |
| FY 2023 | $22.33B | $42.86B | 44.0% | 44.0% | $1.07B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JCI // BETA 0.98
TMO // BETA 0.94